Rose Geoffrey Beran's Form 4 filing
Pulmonx Corp (LUNG) · filed Jun 3, 2026
- Accession no.
- 0001804146-26-000002
- Filed
- Jun 3, 2026
- Trade date
- Jun 1, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $12.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rose Geoffrey BeranCIK 0001804146 | Officer (CHIEF COMMERCIAL OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | Common Stock | SSaleDisposed | −1,778 | $1.54 | −$2,738.12 | 463,956 | Direct | |
| Jun 1, 2026 | Common Stock | SSaleDisposed | −1,557 | $1.54 | −$2,397.78 | 462,399 | Direct | |
| Jun 1, 2026 | Common Stock | SSaleDisposed | −2,434 | $1.54 | −$3,748.36 | 459,965 | Direct | |
| Jun 1, 2026 | Common Stock | SSaleDisposed | −2,254 | $1.54 | −$3,471.16 | 457,711 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.